Literature DB >> 17242300

Genetic susceptibility to essential hypertension: insight from angiotensinogen.

Jean-Marc Lalouel1, Andreas Rohrwasser.   

Abstract

Although progress in the genetics of essential hypertension may seem disappointing, it has considerable potential in defining research directions that will ultimately translate into clinical practice. The hypothesis that genetic variation at the angiotensinogen locus impacts on individual susceptibility to develop essential hypertension has motivated a substantial body of research by us and many others. We examine how analyses of the mechanisms by which variation in angiotensinogen expression may contribute to disease susceptibility and may have arisen in human populations have progressed in recent years. Although the objective of personalized medicine is still in the future, a genetic hypothesis based on human variation can uniquely empower functional genomics approaches to reach such an ultimate goal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242300     DOI: 10.1161/01.HYP.0000257145.20363.9c

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 3.  Genetic architecture of complex traits predisposing to nephropathy: hypertension.

Authors:  Steven C Hunt
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 4.  The role of the kidney in regulating arterial blood pressure.

Authors:  Hani M Wadei; Stephen C Textor
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

Review 5.  Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension.

Authors:  L Gabriel Navar; Minolfa C Prieto; Ryousuke Satou; Hiroyuki Kobori
Journal:  Curr Opin Pharmacol       Date:  2011-02-19       Impact factor: 5.547

Review 6.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

7.  Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes.

Authors:  W Scott Watkins; Steven C Hunt; Gordon H Williams; Whitney Tolpinrud; Xavier Jeunemaitre; Jean-Marc Lalouel; Lynn B Jorde
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

Review 8.  Opportunities and limitations of genetic analysis of hypertensive rat strains.

Authors:  Juan M Saavedra
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

9.  Response to genetic manipulations of liver angiotensinogen in the physiological range.

Authors:  Barbu Gociman; Andreas Rohrwasser; Elaine Hillas; Tong Cheng; Grant Hunter; Jennifer Hunter; Paul Lott; Smith Monson; Jian Ying; J M Lalouel
Journal:  J Hum Genet       Date:  2008-07-04       Impact factor: 3.172

Review 10.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.